Insulet shares are trading higher after Piper Sandler maintained an Overweight rating on the stock and raised its price target from $230 to $285.
Portfolio Pulse from Benzinga Newsdesk
Insulet shares rose as Piper Sandler maintained an Overweight rating and increased the price target from $230 to $285.
September 17, 2024 | 2:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler's decision to maintain an Overweight rating and raise the price target for Insulet from $230 to $285 has positively impacted the stock price.
The increase in price target and maintained Overweight rating by Piper Sandler suggests strong confidence in Insulet's future performance, likely boosting investor sentiment and driving the stock price higher.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100